Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96.

Cairo, MS, Gerrard, M, Sposto, R, Auperin, A, Pinkerton, R, Michon, J, Perkins, S, Raphael, M, McCarthy, K, Weston, C and Patte, C (2003). Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96.. In: Blood. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, (143A-143A). Dec 06-09, 2003.

Author Cairo, MS
Gerrard, M
Sposto, R
Auperin, A
Pinkerton, R
Michon, J
Perkins, S
Raphael, M
McCarthy, K
Weston, C
Patte, C
Title of paper Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96.
Conference name 45th Annual Meeting of the American-Society-of-Hematology
Conference location San Diego California
Conference dates Dec 06-09, 2003
Proceedings title Blood   Check publisher's open access policy
Journal name Blood   Check publisher's open access policy
Publisher AMER SOC HEMATOLOGY
Publication Year 2003
Year available 2003
Sub-type Published abstract
Open Access Status Not yet assessed
ISSN 0006-4971
Volume 102
Issue 11
Start page 143A
End page 143A
Total pages 1
Language eng
Keyword Hematology
Hematology
HEMATOLOGY
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Sub-type: Blood
Collection: ResearcherID Downloads - Archived
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sat, 09 Jul 2016, 03:31:15 EST by System User